Stada’s head of Europe, Steffen Wagner, is set to become the new CEO of Advanz early next year, while current CEO Graeme Duncan will step down and take a new role as special advisor to the board. Advanz is also appointing a new chief financial officer, with Merck Healthcare’s Andreas Stickler set to succeed Adeel Ahmad in January.
Steffen Wagner will take over as CEO of Advanz • Source: Stada
Advanz Pharma CEO Graeme Duncan is stepping down from his role in early 2022 and will be replaced by Steffen Wagner, the current executive vice-president of European markets at Stada.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
